...
首页> 外文期刊>World neurosurgery >Comparison of Survival Outcomes Between Partial Resection and Biopsy for Primary Glioblastoma: A Propensity Score-Matched Study
【24h】

Comparison of Survival Outcomes Between Partial Resection and Biopsy for Primary Glioblastoma: A Propensity Score-Matched Study

机译:原发性胶质母细胞瘤部分切除和活检之间存活结果的比较:倾向分数匹配研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

ObjectivesGross total resection for glioblastoma (GBM) has been associated with better prognosis. However, it is not always feasible, and the threshold for the extent of resection required for better prognosis has been controversial. Therefore, we compared the survival and clinical outcomes of patients with GBM who had undergone partial resection (PR) or biopsy. MethodsOf the 110 patients, 32 and 78, who had undergone PR and biopsy, respectively, were enrolled to identify any differences in clinical outcomes. No differences were found in patient demographics between the 2 groups, except for tumor location and mean tumor volume (P?= 0.02 andP< 0.01, respectively). Propensity score matching between the PR and biopsy groups was performed, in which 20 patients each in the PR and biopsy groups were matched. ResultsThe overall survival (OS) and progression-free survival (PFS) did not differ significantly between the PR and biopsy groups (P?= 0.84 andP?= 0.48, respectively). After propensity score matching, the differences in OS and PFS between the 2 groups were still not statistically significant (P?= 0.51 andP?= 0.75, respectively). The hazard ratios for OS and PFS for the PR group compared with biopsy were 0.98 and 0.73, respectively; however, the difference was not statistically significant (P?= 0.96 andP?= 0.39, respectively). The surgical complication rate was greater in the PR group (14 of 32; 43.7%) than in the biopsy group (9 of 78; 11.5%;P< 0.01). ConclusionsPR failed to improve survival compared with biopsy for patients with GBM. Moreover, the surgical complication rate in the PR group was greater than that in the biopsy group.
机译:玻璃母细胞瘤(GBM)的玻璃总切除术与更好的预后有关。然而,它并不总是可行的,并且更好预后所需的切除程度的阈值已经存在争议。因此,我们将患者的生存和临床结果进行了患者,患有部分切除(PR)或活组织检查的GBM。方法分别进行了110名患者,32和78,分别涉及PR和活检的方法,以识别临床结果的任何差异。除肿瘤位置和平均肿瘤体积外,在2组之间的患者人口统计学中没有发现差异(P?= 0.02 andp <0.01)。进行PR和活检基团之间的倾向分数匹配,其中PR和活检基团中的20名患者均匹配。结果,PR和活检组之间的总存活(OS)和无进展生存(PFS)没有显着差异(P?= 0.84 andp?= 0.48)。在倾向得分匹配之后,2组之间的OS和PFS的差异仍然没有统计学意义(p?= 0.51 andp?= 0.75)。与活检相比,PR组的OS和PFS的危险比分别为0.98和0.73;然而,差异没有统计学意义(p?= 0.96 andp?= 0.39)。 PR组的手术并发症率大于活组织检查组中的PR组(14个; 43.7%,共78%; 11.5%; P <0.01)。结论与GBM患者的活检相比未能改善生存率。此外,PR组的外科并发症率大于活组织检查组中的外科并发症率。

著录项

  • 来源
    《World neurosurgery》 |2019年第2019期|共9页
  • 作者单位

    Department of Neurological Surgery Asan Medical Center University of Ulsan College of Medicine;

    Department of Neurological Surgery Asan Medical Center University of Ulsan College of Medicine;

    Department of Pathology Asan Medical Center University of Ulsan College of Medicine;

    Department of Radiology Asan Medical Center University of Ulsan College of Medicine;

    Department of Neurological Surgery Asan Medical Center University of Ulsan College of Medicine;

    Department of Radiology Asan Medical Center University of Ulsan College of Medicine;

    Department of Neurological Surgery Asan Medical Center University of Ulsan College of Medicine;

    Department of Neurological Surgery Asan Medical Center University of Ulsan College of Medicine;

    Department of Radiology Asan Medical Center University of Ulsan College of Medicine;

    Department of Neurological Surgery Asan Medical Center University of Ulsan College of Medicine;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 外科学各论;
  • 关键词

    Biopsy; Glioblastoma; Partial resection; Survival;

    机译:活检;胶质母细胞瘤;部分切除;生存;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号